藥物成份

共有 21216 個藥物成份

PYROZYME

• 關聯藥證數量: 1

PYRROLIDINONE POLYMER

• 關聯藥證數量: 1

PYRROLNITRIN

• 關聯藥證數量: 1

PYRUVIC ACID

• 關聯藥證數量: 1

PYRVINIUM

• 關聯藥證數量: 1

Package Insert (1).

• 關聯藥證數量: 1

Paclitaxel (2nd) contains not less than 97.0 percent and not more than 102.0 percent of C47H51NO14 calculated on the anhydrous basis.

• 關聯藥證數量: 1

Paclitaxel contains not less than 97.0 percent and not more than 102.0 percent of C47H51NO14.

• 關聯藥證數量: 1

Paclitaxel contains not less than 97.0% and not more than 102.0% of C47H51NO14, calculated on the anhydrous, solvent-free basis.

• 關聯藥證數量: 1

Paclitaxel contains not less than 99.0% and not more than 101.0% of C47H51NO14, calculated on the anhydrous, solvent-free basis.

• 關聯藥證數量: 1

Paliperidone contains NLT 98.0% and NMT 102.0% of Paliperidone (C23H27FN4O3).

• 關聯藥證數量: 1

Paliperidone contains not less than 98.0% and not more than 102.0% of C23H27FN4O3, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Paliperidone palmitate contains not less than 98.0% and not more than 102.0% of C39H57FN4O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Palonosetron Hydrochloride contains 98.0% ~ 102.0% of C19H24N2O‧HCl, calculated on the dried basis

• 關聯藥證數量: 1

Panoscreen I & II : a two-vial set. Each vial contain a 2-4% suspension of single donor, group O red cells prepared in a buffered preservative solution containing adenosine and adenine to retard hemolysis and/or loss of antigenicity during the dating period. Chloramphenicol(0.25 mg/mL), neomycin sulfate(0.1mg/mL) and gentamycin sulfate(0.05mg/mL) have been added as preservatives.

• 關聯藥證數量: 1

Pantoprazole Sodium Contains not less than 99 percent and not more than 101 percent of C16H14F2N3NaO4S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Pantoprazole Sodium Sesquihydrate contains not less than 99.0% and not more than 101.0% of C16H14F2N3NaO4S‧1 1/2H2O, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Pantoprazole Sodium Sesquihydrate contains not less than 99.0% and not more than 101.0%.

• 關聯藥證數量: 1

Pantoprazole Sodium Sesquihydrate, Content: 99.0 per cent to 101.0 per cent (anhydrous substance).

• 關聯藥證數量: 1

Pantoprazole Sodium contains NLT 98.0% and NMT 102.0% of C16H14F2N3NaO4S．3/2 H2O, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Pantoprazole Sodium contains not less than 98.0% and not more than 102% of C16H14F2N3NaO4S, calculated on anhydrous basis.

• 關聯藥證數量: 1

Pantoprazole Sodium contains not less than 98.0% and not more than 102.0% of C16H14F2N3NaO4S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Pantoprazole Sodium contains not less than 99% and not more than 101% of C16H14F2N3NaO4S, calculated on the dried basis.

• 關聯藥證數量: 1

Pantoprazole hemimagnesium monohydrate

• 關聯藥證數量: 1

Pantothenol (Dexpanthenol) contains not less than 98.0% and not more than 102% of dexpantothenol(C9H19NO4), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Paracetamol N-(4-Hydroxyphenyl)acetamide. Content:99.0 per cent to 101.0 per cent (dried substance).

• 關聯藥證數量: 1

Paracetamol (Acetaminophen) contains not less than 99.0% and not more than 101.0% of C8H9NO2, calculated on the dried substance.

• 關聯藥證數量: 1

Paracetamol contains 99.0%~101% of C8H9NO2, calculated on dried basis.

• 關聯藥證數量: 1

Paracetamol contains not less than 99% and not more than 101% of C8H9NO2, calcuclated on the anhydrous basis.

• 關聯藥證數量: 1

Paracetamol contains not less than 99.0 per cent and not more than the equivalent of 101.0 per cent of C8H9NO2 calculated with reference to the dried substance.

• 關聯藥證數量: 1

Paracetamol contains not less than 99.0% and not more than 101.0% of C8H9NO2, calculated on the dried substance.

• 關聯藥證數量: 1

Paracetamol contains not less than 99.0% and not more than the equivalent of 101.0% of C20H21NO4,HCl, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Paracetamol contaions not less than 99.0% and not more than 101.0% of C8H9NO2,calculated on the dried substance.

• 關聯藥證數量: 1

Parainfluenza 1 monoclone antibidy conjugated FITC,\nParainfluenza 2 monoclone antibidy conjugated FITC,\nParainfluenza 3 monoclone antibidy conjugated FITC,\nPositive Control Slide,\nMounting medium.

• 關聯藥證數量: 1

Parecoxib Sodium contains NLT 98.0% and NMT 102.0% of C19H17N2NaO4S, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Parecoxib Sodium contains not less than 98.0% and not more than 102.0% of C19H17N2O4SNa, calculated on the dried basis.

• 關聯藥證數量: 1

Parecoxib Sodium contains not less than 98.5% and not more than 101.5% of C19H17N2O4SNa, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Parecoxib Sodium contains not less than 98.5% and not more than 102.0% of C19H17N2O4SNa, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Parecoxib sodium contains not less than 98.0% and not more than 102.0% of C19H17N2O4SNa, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Paricalcitol contains 97.0%~103.0% (dried basis)

• 關聯藥證數量: 1

Paritaprevir

• 關聯藥證數量: 1

Parotitis Virus: 1. Antigen 2. Control Antigen 3. Postive Control 4. Negative Control.

• 關聯藥證數量: 1

Paroxetine Hydrochloride Hemihydrate contains not less than 97.5% and not more than 102.0% of C19H21ClFNO3‧1/2H2O, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Paroxetine Hydrochloride Hemihydrate contains not less than 98.5% and not more than 102.0% of C19H20FNO3 · HCl · ½H2O, calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Paroxetine Hydrochloride Hemihydrate contains not less than 98.5% and not more than 102.0% of C19H21ClFNO3‧1/2H2O, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Paroxetine Hydrochloride contains not less than 98.5 percent and not more than 102.0 percent of C19H20FNO3‧HCl, calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Paroxetine Hydrochloride hemihydrate Content: 98.5% to 101.5% (Anhydrous substance)

• 關聯藥證數量: 1

Part A Substrate ─urea peroxide.

• 關聯藥證數量: 1

Part A: DNA Pol. (red cap) 1 x 55 μL, TSM (orange cap) 2 x 1.1 mL\nPart B: E1 1 x 20 mL, E2 8 x 1.3 mL, DR. Hyb Buffer 1 x 15 mL, Blocking Reagent 1 x 80 mL, Strep-AP (colorless cap) 2 x 30 μL, NBT/BCIP (brown cap) 2 x 0.6 mL, Detection Buffer 1 x 120 mL, Wash Buffer 2 x 200 mL, DR. TB-SC Chip 12 x 8 Rx, 96 Well Plate Cage 1 case, Plastic Membrane 1 Piece, User’s Guide 1 set\n

• 關聯藥證數量: 1

Part B Substrate─tetramethylbenzidine.

• 關聯藥證數量: 1

Particle Bound Anti-Streptolysin O (Recombinant) 691ug/mL

• 關聯藥證數量: 1

Particle Bound Human Gamma Globulin 6591 ug/mL

• 關聯藥證數量: 1

Particle Bound Theophylline:4.7 mL;Mouse Monoclonal Anti-Theophylline: 5.2mL

• 關聯藥證數量: 1

Particle Reagent, Buffer, and Antibody.

• 關聯藥證數量: 1

Particle Reagent、Buffer、Antibody、0.5N NaOH

• 關聯藥證數量: 1

Particles: 1.1%\nEthanol: 9.4%\nHydrochloric acid 0.5%

• 關聯藥證數量: 1

Patisiran sodium

• 關聯藥證數量: 1

Pefloxacin (Methanesulfonate)

• 關聯藥證數量: 1

Pegaspargase

• 關聯藥證數量: 1

Pegfilgrastim

• 關聯藥證數量: 1

Pegunigalsidase alfa

• 關聯藥證數量: 1

Pelikloon anti-C3d monoclonal is producted as culture supernatants from stable hybridoma cell lines.

• 關聯藥證數量: 1

Pelikloon anti-D mix(IgG/IgM)monoclonal blood grouping reagent is prepared from culture supernatant from stable hybridoma cell lines. \nThis monoclonal reagent contains human IgG/IgM antibodies.\n

• 關聯藥證數量: 1

Pelikloon anti-K (IgM) monoclonal blood grouping reagent are prepared from culture supernatants from stable hybridoma cell lines.\nThis monoclonal reagent contain human IgM antibodies. \n

• 關聯藥證數量: 1

Pelikloon monoclonal blood grouping reagents are prepared from culture supernatants from stable hybridoma cell lines. These monoclonal reagents contain human (S ) IgM antibodies.\n\n

• 關聯藥證數量: 1

Pelikloon monoclonal blood grouping reagents are prepared from culture supernatants from stable hybridoma cell lines. These monoclonal reagents contain murine(Lea ) or IgM antibodies.\n\n

• 關聯藥證數量: 1

Pelikloon monoclonal blood grouping reagents are prepared from culture supernatants from stable hybridoma cell lines. These monoclonal reagents contain murine(Leb ) IgM antibodies.

• 關聯藥證數量: 1

Pelikloon monoclonal blood grouping reagents are prepared from culture supernatants from stable hybridoma cell lines. These monoclonal reagents contain murine(P1 ) IgM antibodies.

• 關聯藥證數量: 1

Pelikloon polyspecific anti-human serum contains polyclonal IgG and monoclonal anti-C3d antibodies.\nThis product is also supplied as a green coloured reagent.

• 關聯藥證數量: 1

Pemetrexed Disodium Hemipentahydrate Assay 98.0%~102.0%, as anhydrous substance.

• 關聯藥證數量: 1

Pemetrexed Disodium Hemipentahydrate contains 98.0%~102.0% of C20H19N5Na2O6‧2.5H2O (anhydrous substance).

• 關聯藥證數量: 1

Pemetrexed Disodium Hemipentahydrate contains not less than 97.5% and not more than 102.0% of C20H19N5Na2O6 Calculated on the anhydrous basis.

• 關聯藥證數量: 1

Pemetrexed Disodium contains not less than 97.5 percent and not more than 102.0 percent of C20H19N5Na2O6 calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Penicillin G 10 units/disc

• 關聯藥證數量: 1

Pentosan Polysulfate Sodium contains not less than 95.0 percent of (C5H6Na2O10S2)n, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Pentoxifylline contains 99.0% to 101.0% of C13H18N4O3 (Dried substance)

• 關聯藥證數量: 1

Pentoxifylline contains not less than 98.0% and not more than 102.0% of C13H18N4O3, calculated on the dried basis.

• 關聯藥證數量: 1

Pentoxifylline contains not less than 99.0 % and not more than 101.0 % of C13H18N4O3, calculated on the dried substance.

• 關聯藥證數量: 1

Pentoxifylline contains not less than 99.0% and not more than 101.0% of C13H18N4O3, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Pentoxifylline contains not less than 99.0% and not more than 101.0% of C13H18N4O3, calculated on the dried basis.

• 關聯藥證數量: 1

Pentoxifylline contains not less than 99.0% and not more than 101.0% of C13H18N4O3, calculated on the dried substance.

• 關聯藥證數量: 1

Pentoxifylline contains not less than 99.0% and not more than 101.0% of C13H18N4O3.

• 關聯藥證數量: 1

Pentoxyverine Citrate

• 關聯藥證數量: 1

Peptone 25.7g

• 關聯藥證數量: 1

Peptones (porcine or bivine) 17.2g、 L. tryptophan 0.9g、 Hepes buffer 0.4g、 Chromogenic medium 6.87g、 Agar 18g、 Purified water 1l

• 關聯藥證數量: 1

Peptones (porcine or bovine) 17.2 g\nL- Tryptophan 0.9 g\nHepes buffer 0.4 g\nMixture of chromogenic substrates 6.87 g\nSelective mixture 0.38 g\nAgar 18 g\nPurified water 1 L

• 關聯藥證數量: 1

Peramivir Hydrate contains not less than 98.0% and not more than 102.0% of C15H28N4O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Peramivir hydrate (Polymorphism A type) contains not less than 97.0% and not more than 103.0%, calculated on the dried basis.

• 關聯藥證數量: 1

Perfluorobutane microbubbles

• 關聯藥證數量: 1

Perfluoropropane

• 關聯藥證數量: 1

Perindopril Erbumine contains not less than 99.0% and not more than 101.0% of C19H32N2O5‧C4H11N calculated on the dried basis.

• 關聯藥證數量: 1

Permethrin(25:75) (C21H20Cl2O3) contains not less than 98.0 per cent to 102.0 per cent (anhydrous substance).

• 關聯藥證數量: 1

Peroxidase ≧ 2 kU/l

• 關聯藥證數量: 1

Peroxidase(POD)

• 關聯藥證數量: 1

Peroxyacetic Acid.....1.73%\nHydrogen peroxide.....5.95%\nAcetic acid.....17%\nDemineralized Water.....74.32%\nHydroxyethylene-1, 1-diphosphonic acid.....1.0%\n以下空白

• 關聯藥證數量: 1

Pertuzumab

• 關聯藥證數量: 1

Pethidine HCl contains 99.0% and 101.0% of C15H21NO2‧HCL calculated on the dried substance.

• 關聯藥證數量: 1

Pethidine Hydrochloride contains not less than 99.0 % and not more than 101.0 % of C15H21NO2‧HCl (dried substance).

• 關聯藥證數量: 1

Pethidine hydrochloride Assay 99.0% to 101.0% (dried substance)

• 關聯藥證數量: 1

Petrolatum.....94.8%\nBismuth Subgallate.....4.5%\nBorneol.....0.7%\n以下空白

• 關聯藥證數量: 1